Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Laban

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Immunotherapy|August 30, 2019
Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancerJohannes Doescher, Stephanie E Weissinger, Stefan S Schönsteiner, et al.
Scientific Reports|February 9, 2026
Immune checkpoint inhibition increases antigen-specific T cell response in head and neck cancerPatrick J Schuler, Franziska Oliveri, Lisa Puntigam, et al.
Frontiers in Medicine|May 14, 2021
Performance of Different Diagnostic PD-L1 Clones in Head and Neck Squamous Cell CarcinomaJulika Ribbat-Idel, Franz F Dressler, Rosemarie Krupar, et al.
Ebiomedicine|December 12, 2025
Evaluation of an HPV16-L1 antibody rapid test for oropharyngeal cancer diagnosis: diagnostic accuracy and challenges in real-world settingsJohannes M A Kusters, Nicole Brenner, Johannes A Bogaards, et al.
Head & Neck|February 14, 2016
Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neckJohannes A Veit, Daniela Heine, Julia Thierauf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 23, 2015
Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrestMalte Kriegs, Kristin Gurtner, Yildiz Can, et al.
Cancers|March 25, 2022
Patterns of Tumor Infiltrating Lymphocytes in Adenoid Cystic Carcinoma of the Head and NeckJohannes Doescher, Moritz Meyer, Christoph Arolt, et al.
International Journal of Cancer|February 1, 2014
Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancerSimon Laban, Djordje Atanackovic, Tim Luetkens, et al.
Cancer Medicine|December 1, 2023
Regional outcome disparities in German head and neck cancer patients: Shorter survival in Eastern GermanyJulius M Vahl, Gabriele Nagel, Tsima Abou Kors, et al.
Oral Oncology|November 16, 2024
Immune checkpoint expression on tumor-infiltrating lymphocytes (TIL) is dependent on HPV status in oropharyngeal carcinoma (OPSCC) - A single-cell RNA sequencing analysisAdrian von Witzleben, Ayla Grages, Jaya Thomas, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Immunotherapy|August 30, 2019
Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancerJohannes Doescher, Stephanie E Weissinger, Stefan S Schönsteiner, et al.
Scientific Reports|February 9, 2026
Immune checkpoint inhibition increases antigen-specific T cell response in head and neck cancerPatrick J Schuler, Franziska Oliveri, Lisa Puntigam, et al.
Frontiers in Medicine|May 14, 2021
Performance of Different Diagnostic PD-L1 Clones in Head and Neck Squamous Cell CarcinomaJulika Ribbat-Idel, Franz F Dressler, Rosemarie Krupar, et al.
Ebiomedicine|December 12, 2025
Evaluation of an HPV16-L1 antibody rapid test for oropharyngeal cancer diagnosis: diagnostic accuracy and challenges in real-world settingsJohannes M A Kusters, Nicole Brenner, Johannes A Bogaards, et al.
Head & Neck|February 14, 2016
Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neckJohannes A Veit, Daniela Heine, Julia Thierauf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 23, 2015
Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrestMalte Kriegs, Kristin Gurtner, Yildiz Can, et al.
Cancers|March 25, 2022
Patterns of Tumor Infiltrating Lymphocytes in Adenoid Cystic Carcinoma of the Head and NeckJohannes Doescher, Moritz Meyer, Christoph Arolt, et al.
International Journal of Cancer|February 1, 2014
Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancerSimon Laban, Djordje Atanackovic, Tim Luetkens, et al.
Cancer Medicine|December 1, 2023
Regional outcome disparities in German head and neck cancer patients: Shorter survival in Eastern GermanyJulius M Vahl, Gabriele Nagel, Tsima Abou Kors, et al.
Oral Oncology|November 16, 2024
Immune checkpoint expression on tumor-infiltrating lymphocytes (TIL) is dependent on HPV status in oropharyngeal carcinoma (OPSCC) - A single-cell RNA sequencing analysisAdrian von Witzleben, Ayla Grages, Jaya Thomas, et al.
Pageof 10